News Watchful Waiting While not beginning immediate treatment can sometimes be challenging for people, research has shown that…adminApril 3, 2013
News Continued Support of Lymphoma Research Donations are the driving force that allows Lymphoma Canada (LC) to move forward in providing…adminApril 3, 2013
News Early Detection of Lymphoma in Primary Care Most Canadians rely on their Primary Care Physician (PCP) to be educated in all medical…adminApril 3, 2013
News Canadian Institute for Health Research doubles gifts to LC Do you believe things happen for a reason? I would like to share with you…lauradMarch 15, 2013
News Celebrating Health Canada’s Approval of ADCETRIS Lymphoma Canada celebrates Health Canada’s Approval of ADCETRIS (Brentuximab Vedotin) (more…)lauradFebruary 13, 2013
Research Rituximab and Elderly Mantle Cell Patients A study published in the New England Journal of Medicine showed that maintenance theraphy with…lauradDecember 1, 2012
Research Bendamustine for treatment of iNHL and MCL Lymphoma is the fifth most common malignancy in Canada that is expected to cause 2800…lauradDecember 1, 2012
Research Bendamustine added to BC Drug Benefit List The BC Cancer Agency, in the November 2012 Systemic Therapy Update, has added bendamustine (Treanda®)…lauradNovember 13, 2012
Research New Treatment Option for Relapsed Indolent B-cell Non-Hodgkin Lymphoma MONTREAL, QUEBEC, Sep 13, 2012 (MARKETWIRE via COMTEX) -- Editors note: There is a video…lauradSeptember 13, 2012
News World Lymphoma Awareness Day 2012 2012 World Lymphoma Awareness Day Saturday, September 15, 2012 We are extremely proud to be…lauradSeptember 13, 2012